It's never too late to start exercising and losing weight , Joslin study shows

December 04, 2003

BOSTON - There's good news on the research front for those who want to shed some pounds and get in shape this holiday season. A new study by Joslin Diabetes Center researchers shows that obese adults who lost just 7 percent of their weight - or 16 pounds in a 220-pound, 5'5" tall woman - and did moderate-intensity physical exercise for six months improved their major blood vessel function by approximately 80 percent, regardless of whether or not they had type 2 diabetes.

"This means that it is never been too late to intervene in order to prevent progression of atherosclerosis," said Osama Hamdy, M.D., lead author of the study, recently published in Diabetes Care. "Altered function of the endothelium, the inner lining layer of the blood vessels, is an early stage in atherosclerosis that eventually leads to coronary artery disease and heart attack or stroke, which are the leading causes of death in at least 75 percent of patients with type 2 diabetes," said Dr. Hamdy, a Joslin physician who specializes in obesity. This thin layer inside the artery secretes a substance called nitric oxide that causes the arteries to dilate and improves blood flow. "In the majority of people with type 2 diabetic and even in many obese individuals who do not have diabetes the function of this layer is altered, initiating the atherosclerotic process," he said.

Diabetes affects an estimated 18.2 million Americans, about one-third of whom do not even know they have the disease. Type 2 diabetes, the most common form of diabetes, traditionally was considered a disease of middle-aged and older adults. Type 2 diabetes is increasingly occurring in young people and children due in large part to increasing obesity and sedentary lifestyle. Diabetes is a leading cause of heart disease, stroke, blindness, kidney disease and nerve damage. Coronary artery blockage remains a major killer among people with diabetes, he said.

How the study was conducted

The study of 35 obese subjects included three groups of volunteers; all were obese and had a body mass index above 30 kg/m2 had insulin resistance. It has been known that obese individuals, especially those with a family history of diabetes, have a condition called insulin resistance syndrome, syndrome-X or the metabolic syndrome years before they develop type 2 diabetes, Dr. Hamdy explained. Metabolic syndrome is seen in 23.7 percent of all adult Americans above age 20 and in approximately 40 percent of those above age 60, according to a recent survey. This condition puts them at higher risk for developing type 2 diabetes, high blood pressure and high cholesterol and triglycerides and can lead to an increased tendency for blood clotting and coronary artery disease. This condition also is associated with low-grade inflammation caused by several substances secreted by the body fat and, in particular, the internal fat in the waistline (intra-abdominal or visceral fat).

The first group in the Joslin study did not have diabetes; the second group had a condition known as impaired glucose tolerance and was at high risk for developing diabetes; and the third group had type 2 diabetes. The three groups were put on a calorie-restricted diet, simply by cutting 500 calories from their daily caloric consumption.

The participants also exercised in the gym at Joslin in Boston two to three times per week. Exercise was moderate in intensity and for 30 minutes each session using both upper and lower body like brisk walking or mild running on a treadmill with movement of the upper body, or using the stationary bike and rowing machine.

"After 6 months, the study participants had lost an average of about 7 percent of their initial weight or approximately 16 pounds in a 220-pound person," Dr. Hamdy said.

The researchers found significant improvement in the function of the major blood vessels; as their capacity to dilate in response to the nitric oxide secreted by the endothelium improved significantly, their risk of developing arteriosclerosis and heart disease was reduced, Dr. Hamdy said. The researchers also found improvement in several markers of blood coagulation, inflammation and vascular activity, which are usually altered in this population, putting them at higher risk for developing coronary artery disease.

Significance of the findings

"The important finding of this study is that a weight loss as low as 7 percent can improve or reverse the early abnormalities of blood vessels that lead to atherosclerosis and coronary heart disease and that obese people get equal clinical benefit from weight loss, whether they have diabetes, pre-diabetes or have normal blood glucose levels," Dr. Hamdy said. These latest findings are consistent with those of the recently completed national Diabetes Prevention Program (type 2 diabetes study), which was conducted at Joslin and other institutions. The DPP showed modest weight loss and regular exercise, like brisk walking, reduced the risk of developing type 2 diabetes in people at risk by 58 percent.

"Now that we have the results of this study as well as the DPP findings, it's more important than ever to get people moving and eating a healthier diet because we know that even modest weight loss and increased physical activity is good for our cardiovascular system," Dr. Hamdy said.
-end-
About Joslin Diabetes Center

Joslin Diabetes Center, the global leader in diabetes research, care and education, is uniquely qualified to lead the battle against diabetes in the 21st century. Joslin Research is a team of over 300 people at the forefront of discovery aimed at preventing and curing diabetes. Joslin Clinic, affiliated with Beth Israel Deaconess Medical Center in Boston, the nationwide network of Joslin Affiliated Programs, and the hundreds of Joslin educational programs offered each year for clinicians, researchers and patients, enable Joslin to develop, implement and share innovations that immeasurably improve the lives of people with diabetes. As a nonprofit, Joslin benefits from the generosity of donors in advancing its mission. For more information on Joslin, call 1-800-JOSLIN-1 or visit http://www.joslin.org.

For more information, contact:
Marge Dwyer or Jim Soland,
Joslin Communications, 617-732-2415
Marjorie.dwyer@joslin.harvard.edu
James.soland@joslin.harvard.edu

Joslin Diabetes Center

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.